AAMC Issues New Policy Statement
on Cloning
April 12, 2002 - The AAMC April 10 issued a new policy
statement
on cloning. The statement restates the Association's strong
opposition to human reproductive cloning, stating that, "To
expose any person to the known risks and uncertainties involved
in reproductive cloning would be unethical and unconscionable."
The statement stresses that "it is important to recognize
the difference between reproductive cloning and the use of
cloning technology that does not create a human being."
The AAMC statement urges Congress "to oppose legislation
that would prohibit research on the use of nuclear transplantation
to produce stem cells. Such a blanket prohibition would have
grave implications for future advances in medical research
and human healing. Since other nations have already decided
not to enact such law, a Congressional ban would also pose
a serious threat to the continued world leadership of the
United States in medical research and biotechnology."
The AAMC statement concludes that, "The current opportunities
in medical research are unparalleled in our nation's history,
and among the brightest of these is the further study and
application of both adult and embryonic stem cell technology.
The production of stem cells by nuclear transplantation may
yet prove the most powerful and widely beneficial of all.
However, we will never see the fulfillment of any of this
promise if we choose to take the perilous and unprecedented
path of banning through legislation research on nuclear transplantation
to produce stem cells."
Information:
|
Tony Mazzaschi, Senior Associate Vice President
AAMC Biomedical Health Sciences Research
tmazzaschi@aamc.org
(202) 828-0059
|
Dave Moore, Senior Associate Vice President
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525
|

Get Washington Highlights
in your Inbox!
|